Kayani, Irfan <br/><br/>
Sequential FDG-PET/CT as a biomarker of response to Sunitinib in metastatic clear cell renal cancer.  [electronic resource] 

 -  Clinical cancer research : an official journal of the American Association for Cancer Research  Sep 2011 
 - 6021-8 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1557-3265 
<br/><br/><label>Standard No.: </label>10.1158/1078-0432.CCR-10-3309  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antineoplastic Agents--therapeutic use<br/>Carcinoma, Renal Cell--diagnostic imaging<br/>Female<br/>Fluorodeoxyglucose F18<br/>Humans<br/>Indoles--therapeutic use<br/>Kaplan-Meier Estimate<br/>Kidney Neoplasms--diagnostic imaging<br/>Male<br/>Middle Aged<br/>Multimodal Imaging<br/>Neoplasm Metastasis<br/>Positron-Emission Tomography<br/>Prognosis<br/>Pyrroles--therapeutic use<br/>Sunitinib<br/>Tomography, X-Ray Computed<br/>Treatment Outcome